Revance Therapeutics, Inc.

North America Legal Chronicle. August 28, 2024

Crown Laboratories’ $924 Million Merger with Revance Therapeutics

By Laura Testa

Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. September 23, 2022

Revance Therapeutics’ $200 Million Common Stock Offering

By Laura Testa

Cooley represented Revance, while Morgan Lewis represented Goldman Sachs & Co. LLC, Cowen and Company LLC, and Guggenheim Securities LLC, as joint book-running managers in the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

American Tower’s $1.2 Billion Notes Offering

Bloomberg’s Expansion Lease with SL Green Realty

Beacon Power Services’ Series A Raising

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

YPF Luz’s US$420 Million Notes Issuance

Symrise’s Public Offer for Probi

Eleven Ventures’ Investment in Cloud Office

Pivotal’s Acquisition of Security Plus Limited

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Vee Healthtek’s Investment Round

Cathay Pacific Airways Ltd’s HK$6.732 Billion Convertible Bonds Issuance

China Water Affairs Group Limited’s HK$361 Million Exchangeable Bonds Offering

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Crown Laboratories’ $924 Million Merger with Revance Therapeutics

Standard 1 Year Membership Required

Revance Therapeutics’ $200 Million Common Stock Offering

Standard 1 Year Membership Required